Cytosorbents Corp (NASDAQ:CTSO)

9.80
BATS BZX Real-Time Price
As of 9:51am ET
 +0.14 / +1.45%
Today’s Change
3.49
Today|||52-Week Range
11.24
+154.55%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$378.3M

Company Description

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.

Contact Information

CytoSorbents Corp.
7 Deer Park Drive
Monmouth Junction New Jersey 08852
P:(732) 329-8885
Investor Relations:
17323298885394

Employees

Shareholders

Individual stakeholders20.93%
Other institutional16.20%
Mutual fund holders11.34%

Top Executives

There are no executives to display.